Title of the Paper: Unveiling naringenin's therapeutic potential in a rat model of postmenopausal cardiovascular complications: integrated in silico and in vivo experimental approaches
Journal: European Journal of Pharmacology
DOI: 10.1016/j.ejphar.2025.177951
Publication Year: 2025
Description:
This study, published in the European Journal of Pharmacology, focused on investigating naringenin as a non-hormonal alternative to estrogen in mitigating postmenopausal cardiovascular complications. A significant aspect of this work involved meticulous data validation, review, and statistical analysis to ensure the accuracy and reliability of the findings.
The research process included rigorous statistical modeling and the application of advanced statistical tests to analyze experimental data, such as ANOVA test. These analyses were conducted to draw meaningful conclusions and ensure that the results could be confidently interpreted and applied in pharmacological contexts.
The methodological rigor and statistical accuracy underpinning this study make it a valuable resource for future pharmacological research.